Attention Investors: Time is Running Out! Faruqi & Faruqi LLP Investigates Claims for Kyverna Therapeutics Investors

Attention Investors: Time is Running Out! Faruqi & Faruqi LLP Investigates Claims for Kyverna Therapeutics Investors Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Kyverna To Contact Him Directly To Discuss Their Options. If you suffered losses exceeding $50,000 investing

Read More »

Breaking News: uniQure Set to Launch Exciting Public Offering in 2025!

Breaking News: uniQure Set to Launch Exciting Public Offering in 2025! Introduction LEXINGTON, Mass. and AMSTERDAM, Jan. 07, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it has commenced an underwritten public offering

Read More »